Clinical Trials on High-Risk Prostate Cancer
Total 7437 results
-
Martin T. King, MD, PhDBlue Earth Diagnostics; Dana-Farber/Brigham and Women's Cancer CenterRecruitingProstate Cancer | Intermediate Risk Prostate Cancer | High Risk Prostate CancerUnited States
-
Azienda Socio Sanitaria Territoriale degli Spedali...TakedaUnknownIntermediate Risk Prostate Cancer | High Risk Prostate CancerItaly
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruitingHigh-risk Prostate CancerItaly
-
Rabin Medical CenterRecruitingHigh Risk Prostate CancerIsrael
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Novartis PharmaceuticalsNot yet recruiting
-
BayerRecruiting
-
Heinrich-Heine University, DuesseldorfMedical University of Vienna; KU Leuven; Erasmus Medical Center; Ludwig-Maximilians... and other collaboratorsActive, not recruitingHigh-risk Prostate Cancer | Intermediate-risk Prostate CancerBelgium, Germany, Austria, Switzerland, Sweden, India, Italy
-
Radboud University Medical CenterNot yet recruitingHigh Risk Localized Prostate Cancer | Synchronous Metastatic Hormone-Sensitive Prostate Cancer
-
Thomas HopeNovartisRecruitingProstate Cancer | Localized Prostate Carcinoma | Prostate Cancer (Diagnosis) | High-risk Prostate Cancer | Very High Risk Prostate CarcinomaUnited States
-
The Methodist Hospital Research InstituteRecruitingProstate Cancer | High-risk Prostate CancerUnited States
-
Won KimNovartisTerminated
-
Sunnybrook Health Sciences CentreProstate Cancer CanadaUnknownHIGH RISK PROSTATE CANCERCanada
-
Sergio FariaCompletedHigh Risk Prostate CancerCanada
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Copenhagen University... and other collaboratorsRecruitingProstate Cancer Patients Undergoing External Radiation and Seed Implantation | Locally Advanced Prostate Cancer | High Risk Localised Prostate Carcinoma | Unfavourable Intermediate Risk Prostate CancerDenmark
-
Hongqian GuoRecruitingNeoadjuvant Therapy \High Risk Prostate CancerChina
-
Hongqian GuoActive, not recruitingNeoadjuvant Therapy \ High Risk Prostate Cancer \ DocetaxelChina
-
Cellvax Therapeutics IncRecruitingProstate Cancer | Prostate Cancer (Adenocarcinoma) | Prostate Cancer Patients Undergoing Radical Prostatectomy | High-risk Prostate Cancer | Prostate CA | Prostate Cancers | Prostate Cancer (Post Prostatectomy)United States
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...RecruitingNeoadjuvant Therapy | High Risk Prostate Cancer | Locally Advanced Prostate Cancer | Intense Endocrine TherapyChina
-
General University Hospital, PragueUniversity Hospital Olomouc; Ústřední fakultní vojenská nemocnice, Praha, Czechia and other collaboratorsActive, not recruitingProstate Cancer | High Risk Prostate Cancer | PSMA PET | Staging
-
Turku University HospitalUniversity of TurkuCompleted
-
AmgenActive, not recruitingProstate Cancer | High-risk Biochemical Recurrence | High Risk Biochemical Recurrence of Non-metastatic Castration-sensitive Prostate Cancer | Non-metastatic Castration-sensitive Prostate CancerUnited States, Australia
-
Center Eugene MarquisRecruitingHigh Risk Prostate CancerFrance
-
Dana-Farber Cancer InstituteMedivation, Inc.CompletedProstate Cancer | Prostate Adenocarcinoma | High Risk Prostate CancerUnited States
-
AstraZenecaCompletedPostoperative or Postradiation Adjuvant Androgen Deprivation Therapy in Locally Advanced Prostate Cancer (High and Very High Risk) PatientsRussian Federation
-
AHS Cancer Control AlbertaTerminatedHigh-risk Prostate CancerCanada
-
Icahn School of Medicine at Mount SinaiBayer; Merck Sharp & Dohme LLCRecruitingProstate Cancer | High-risk Prostate CancerUnited States
-
Istituto Clinico Humanitasaccord healthcare italia srlRecruiting
-
Marco OderdaRecruiting
-
Edwin Posadas, MDRecruitingHigh-risk Prostate CancerUnited States
-
ImmunityBio, Inc.Withdrawn
-
VA Office of Research and DevelopmentRecruiting
-
Assistance Publique - Hôpitaux de ParisRecruitingHigh-risk Prostate CancerFrance
-
Johnson & Johnson International (Singapore) Pte...CompletedHigh Risk Localized Prostate CancerJapan, Korea, Republic of, Taiwan
-
German Cancer Research CenterUniversity Hospital Freiburg; ABX CRO; Friedrich-Alexander-Universität Erlangen-NürnbergCompletedProstate Cancer | Prostate Cancer Metastatic | High-risk Prostate Cancer | Lymphnode MetastasisAustria, Germany
-
Jiangsu HengRui Medicine Co., Ltd.TerminatedPatients With High-risk Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical ProstatectomyChina
-
Fudan UniversityActive, not recruitingNeoadjuvant Therapy | High-risk Prostate CancerChina
-
OHSU Knight Cancer InstituteMerck Sharp & Dohme LLC; Oregon Health and Science UniversityWithdrawnStage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | High Risk Prostate Carcinoma | Localized Prostate AdenocarcinomaUnited States
-
Zhujiang HospitalRecruitingHigh-Risk and Oligometastatic Prostate CancerChina
-
West China HospitalRecruitingProstate Cancer | Efficacy | Safety | Stereotactic Body Radiotherapy | High-riskChina
-
Ivan de Kouchkovsky, MDRecruitingProstate Cancer | High Risk Prostate CarcinomaUnited States
-
UNICANCERBayerRecruitingProstate Cancer | High Risk Prostate CarcinomaFrance, Martinique
-
RPCR, Inc.UnknownProstate Cancer Early Risk Treated by Radiosurgery | Prostate Cancer Intermediate Risk Treated by RadiosurgeryUnited States
-
NHS LothianRecruitingLow Risk Prostate Cancer | Intermediate Risk Prostate Cancer | Localized Prostate CancerUnited Kingdom
-
Xijing HospitalLanZhou University; Shaanxi Provincial People's Hospital; Air Force Military... and other collaboratorsRecruitingHigh-risk Prostate Cancer | PSMA PET | Treatment Response | Therapy MonitoringChina
-
University of Texas Southwestern Medical CenterCompletedHigh-Risk Cancer
-
Fundación de Investigación Biomédica - Hospital...CompletedPatients With High-risk Prostate CancerSpain
-
FutureChemActive, not recruitingHigh Risk Prostate CarcinomaKorea, Republic of
-
Rana McKay, MDUniversity of California, San Diego; AstraZenecaRecruitingProstate Cancer | BRCA1 Mutation | BRCA2 Mutation | Prostatic Adenocarcinoma | High-Risk CancerUnited States
-
Prisma Health-UpstateRecruiting